We're keeping an eye on new influenza and SARS-CoV-2 viral variants. Here's what we know about those viruses—and your immune system's ability to fight back. As flu season lingers unusually late, UAB experts explain how influenza spreads, why symptoms occur, which prevention strategies truly work, and when vaccination, antivirals and medical care can help ...

Context Explanation

The Virgin Islands Consortium: Influenza Hit Highest Level in Five Years as USVI Expanded Lead, Legionella and Wastewater Surveillance Influenza Hit Highest Level in Five Years as USVI Expanded Lead, Legionella and Wastewater Surveillance Medical Xpress: Immune cells in the nose slow influenza virus, study finds A new study from the University of Gothenburg may help guide the development of better influenza vaccines. Memory cells in the nose slow the influenza virus as soon as it enters the body. They reduce ... Infectious Disease Advisor: Influenza Vaccine Linked to Lower Hospitalization Risk During 2025 to 2026 Season The 2025-2026 flu vaccine reduced influenza-related outpatient visits and hospitalizations despite an antigenically drifted A(H3N2) strain.

Insight Material

Influenza Vaccine Linked to Lower Hospitalization Risk During 2025 to 2026 Season The Conversation: Can I get a free flu shot? And will it cover ‘super K’? Your influenza vaccine questions answered Can I get a free flu shot? And will it cover ‘super K’? Your influenza vaccine questions answered An international group of scientists mapped the spread of the current dominant strain of highly pathogenic avian influenza virus through North American bird populations in 2024.

Final Conclusion

Led by scientists from ... Influenza vaccination significantly reduces the short-term risk for acute myocardial infarction and stroke following a confirmed influenza infection. National Hog Farmer: Pigs bridge gaps in influenza research and vaccine development Essential tools for understanding viral evolution, monoclonal anitbodies guide therapeutic development and inform vaccine design. While influenza mAb development in humans has progressed rapidly, ...